Fund HoldingsVelan Capital Investment Management LP

Total Portfolio Value
$163.21M
Total Bought
$25.13M
Total Sold
$19.89M
Net Transaction
+$5.24M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
MAPLIGHT THERAPEUTICS INC(MPLT)492,893492,893010,02117,66510.82%+7,645
IMMIX BIOPHARMA INC(IMMX)740,0001,085,000+345,0006,74111,1866.85%+4,445
SUTRO BIOPHARMA INC(STRO)512,160512,160012,75817,00410.42%+4,246
AVALO THERAPEUTICS INC(AVTX)185,122324,452+139,3302,7645,9963.67%+3,232
ANTERIS TECHNOLOGIES GLOBAL(AVR)700,000700,00003,8856,8954.22%+3,010
C4 THERAPEUTICS INC(CCCC)0570,000+570,00002,6621.63%+2,662
EDESA BIOTECH INC(EDSA)827,500827,50004,3286,7284.12%+2,400
ADMA BIOLOGICS INC0250,000+250,00002,0931.28%+2,093
REIN THERAPEUTICS INC(RNTX)01,700,000+1,700,00001,7681.08%+1,768
REZOLUTE INC(RZLT)750,000750,00002,2883,9002.39%+1,613
XENCOR INC(XNCR)250,000255,000+5,0003,0154,1062.52%+1,091
NASUS PHARMA LTD(NSRX)359,390359,39007981,2580.77%+460
VERRICA PHARMACEUTICALS INC(VRCA)471,559471,55902,4952,8861.77%+391
NEUMORA THERAPEUTICS INC.(NMRA)80,000230,000+150,0001563910.24%+235
TECTONIC THERAPEUTIC INC(TECX)06,000+6,00002060.13%+206
AN2 THERAPEUTICS INC040,000+40,00001940.12%+194
MACROGENICS INC(MGNX)30,00060,000+30,000872770.17%+191
ABIVAX SA(ABVX)77,00065,630-11,3708,5748,7465.36%+172
SCYNEXIS INC040,000+40,00001630.10%+163
NURIX THERAPEUTICS INC(NRIX)16,00016,00002483880.24%+140
KARYOPHARM THERAPEUTICS INC(KPTI)15,00020,000+5,000841950.12%+112
PRECISION BIOSCIENCES INC(DTIL)40,00040,00002203140.19%+94
ARTIVA BIOTHERAPEUTICS INC(ARTV)25,00025,00001612430.15%+82
REPLIMUNE GROUP INC(REPL)20,00020,00001532210.14%+68
PROTAGONIST THERAPEUTICS INC3,7003,70003904540.28%+64
XILIO THERAPEUTICS INC(XLO)14,28514,28501201370.08%+17
PROQR THRAPEUTICS N V
SHS EURO
45,00045,000073840.05%+11
CORBUS PHARMACEUTICALS HLDGS(CRBP)26,00026,00002442440.15%-0
MINERALYS THERAPEUTICS INC(MLYS)11,00011,00002982970.18%-1
KALARIS THERAPEUTICS INC(KLRS)18,00025,000+7,0001041020.06%-2
OVID THERAPEUTICS INC(OVID)160,000130,000-30,0003553500.21%-5
IMMUNOME INC(IMNM)10,00010,00002192120.13%-7
GOSSAMER BIO INC(GOSS)70,00070,000023120.01%-11
SYNDAX PHARMACEUTICALS INC(SNDX)10,00010,00002342190.13%-15
LARIMAR THERAPEUTICS INC(LRMR)33,00033,00001491010.06%-48
PMV PHARMACEUTICALS INC(PMVP)73,0000-73,000910-91
DESIGN THERAPEUTICS INC(DSGN)20,0000-20,0002130-213
EUPRAXIA PHARMACEUTICALS INC(EPRX)352,000352,00002,5482,3271.43%-222
CONTEXT THERAPEUTICS INC(CNTX)100,00059,700-40,300262330.02%-229
QUOIN PHARMACEUTICALS LTD(QNRX)84,84932,372-52,4775601570.10%-403
ARROWHEAD PHARMACEUTICALS IN(ARWR)6,5000-6,5004080-408
LYELL IMMUNOPHARMA INC(LYEL)102,000105,000+3,0002,0461,4750.90%-571
PROFOUND MED CORP(PROF)285,710170,278-115,4321,8511,1320.69%-719
ROCKET PHARMACEUTICALS INC(RCKT)294,64360,000-234,6431,0552050.13%-850
KAZIA THERAPEUTICS LTD(KZIA)135,3150-135,3151,0070-1,007
JASPER THERAPEUTICS INC(JSPR)2,668,3952,668,39502,3381,1230.69%-1,215
TENAX THERAPEUTICS INC(TENX)583,333549,985-33,3489,3278,0024.90%-1,325
VIRIDIAN THERAPEUTICS INC(VRDN)91,12310,000-81,1231,7821840.11%-1,599
CYTOMX THERAPEUTICS INC.(CTMX)540,000120,000-420,0002,5384500.28%-2,088
PRAXIS PRECISION MEDICINES I(PRAX)100,78188,781-12,00032,47129,72318.21%-2,748
HERON THERAPEUTICS INC(HRTX)8,753,2908,753,29007,0043,7362.29%-3,268
INSPIREMD INC(NSPR)2,099,652148,138-1,951,5143,4221040.06%-3,319
PROTARA THERAPEUTICS INC(TARA)2,834,6522,844,652+10,00014,76910,8676.66%-3,902
EVOMMUNE INC(EVMN)446,255451,255+5,00010,2595,9973.67%-4,262
ESPERION THERAPEUTICS INC NE1,720,0000-1,720,0004,7130-4,713
Page 1 of 1
Velan Capital Investment Management LP — 13F Holdings — Q2 2026 | TickerTrail